Global DTaP Vaccine Market Growth 2023-2029

March 2023 | 78 pages | ID: GBFE7874690FEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

LPI (LP Information)' newest research report, the “DTaP Vaccine Industry Forecast” looks at past sales and reviews total world DTaP Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected DTaP Vaccine sales for 2023 through 2029. With DTaP Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world DTaP Vaccine industry.

This Insight Report provides a comprehensive analysis of the global DTaP Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on DTaP Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global DTaP Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for DTaP Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global DTaP Vaccine.

The global DTaP Vaccine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for DTaP Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for DTaP Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for DTaP Vaccine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key DTaP Vaccine players cover GlaxoSmithKline, Sanofi Pasteur, Ltd. and Merck, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of DTaP Vaccine market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Inactivated Vaccine
• Live Attenuated Vaccine

Segmentation by application

• Government Institution
• Private Sector
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• GlaxoSmithKline
• Sanofi Pasteur, Ltd.
• Merck

Key Questions Addressed in this Report

What is the 10-year outlook for the global DTaP Vaccine market?

What factors are driving DTaP Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do DTaP Vaccine market opportunities vary by end market size?

How does DTaP Vaccine break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global DTaP Vaccine Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for DTaP Vaccine by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for DTaP Vaccine by Country/Region, 2018, 2022 & 2029
2.2 DTaP Vaccine Segment by Type
  2.2.1 Inactivated Vaccine
  2.2.2 Live Attenuated Vaccine
2.3 DTaP Vaccine Sales by Type
  2.3.1 Global DTaP Vaccine Sales Market Share by Type (2018-2023)
  2.3.2 Global DTaP Vaccine Revenue and Market Share by Type (2018-2023)
  2.3.3 Global DTaP Vaccine Sale Price by Type (2018-2023)
2.4 DTaP Vaccine Segment by Application
  2.4.1 Government Institution
  2.4.2 Private Sector
  2.4.3 Other
2.5 DTaP Vaccine Sales by Application
  2.5.1 Global DTaP Vaccine Sale Market Share by Application (2018-2023)
  2.5.2 Global DTaP Vaccine Revenue and Market Share by Application (2018-2023)
  2.5.3 Global DTaP Vaccine Sale Price by Application (2018-2023)

3 GLOBAL DTAP VACCINE BY COMPANY

3.1 Global DTaP Vaccine Breakdown Data by Company
  3.1.1 Global DTaP Vaccine Annual Sales by Company (2018-2023)
  3.1.2 Global DTaP Vaccine Sales Market Share by Company (2018-2023)
3.2 Global DTaP Vaccine Annual Revenue by Company (2018-2023)
  3.2.1 Global DTaP Vaccine Revenue by Company (2018-2023)
  3.2.2 Global DTaP Vaccine Revenue Market Share by Company (2018-2023)
3.3 Global DTaP Vaccine Sale Price by Company
3.4 Key Manufacturers DTaP Vaccine Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers DTaP Vaccine Product Location Distribution
  3.4.2 Players DTaP Vaccine Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR DTAP VACCINE BY GEOGRAPHIC REGION

4.1 World Historic DTaP Vaccine Market Size by Geographic Region (2018-2023)
  4.1.1 Global DTaP Vaccine Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global DTaP Vaccine Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic DTaP Vaccine Market Size by Country/Region (2018-2023)
  4.2.1 Global DTaP Vaccine Annual Sales by Country/Region (2018-2023)
  4.2.2 Global DTaP Vaccine Annual Revenue by Country/Region (2018-2023)
4.3 Americas DTaP Vaccine Sales Growth
4.4 APAC DTaP Vaccine Sales Growth
4.5 Europe DTaP Vaccine Sales Growth
4.6 Middle East & Africa DTaP Vaccine Sales Growth

5 AMERICAS

5.1 Americas DTaP Vaccine Sales by Country
  5.1.1 Americas DTaP Vaccine Sales by Country (2018-2023)
  5.1.2 Americas DTaP Vaccine Revenue by Country (2018-2023)
5.2 Americas DTaP Vaccine Sales by Type
5.3 Americas DTaP Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC DTaP Vaccine Sales by Region
  6.1.1 APAC DTaP Vaccine Sales by Region (2018-2023)
  6.1.2 APAC DTaP Vaccine Revenue by Region (2018-2023)
6.2 APAC DTaP Vaccine Sales by Type
6.3 APAC DTaP Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe DTaP Vaccine by Country
  7.1.1 Europe DTaP Vaccine Sales by Country (2018-2023)
  7.1.2 Europe DTaP Vaccine Revenue by Country (2018-2023)
7.2 Europe DTaP Vaccine Sales by Type
7.3 Europe DTaP Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa DTaP Vaccine by Country
  8.1.1 Middle East & Africa DTaP Vaccine Sales by Country (2018-2023)
  8.1.2 Middle East & Africa DTaP Vaccine Revenue by Country (2018-2023)
8.2 Middle East & Africa DTaP Vaccine Sales by Type
8.3 Middle East & Africa DTaP Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of DTaP Vaccine
10.3 Manufacturing Process Analysis of DTaP Vaccine
10.4 Industry Chain Structure of DTaP Vaccine

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 DTaP Vaccine Distributors
11.3 DTaP Vaccine Customer

12 WORLD FORECAST REVIEW FOR DTAP VACCINE BY GEOGRAPHIC REGION

12.1 Global DTaP Vaccine Market Size Forecast by Region
  12.1.1 Global DTaP Vaccine Forecast by Region (2024-2029)
  12.1.2 Global DTaP Vaccine Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global DTaP Vaccine Forecast by Type
12.7 Global DTaP Vaccine Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 GlaxoSmithKline
  13.1.1 GlaxoSmithKline Company Information
  13.1.2 GlaxoSmithKline DTaP Vaccine Product Portfolios and Specifications
  13.1.3 GlaxoSmithKline DTaP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 GlaxoSmithKline Main Business Overview
  13.1.5 GlaxoSmithKline Latest Developments
13.2 Sanofi Pasteur, Ltd.
  13.2.1 Sanofi Pasteur, Ltd. Company Information
  13.2.2 Sanofi Pasteur, Ltd. DTaP Vaccine Product Portfolios and Specifications
  13.2.3 Sanofi Pasteur, Ltd. DTaP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Sanofi Pasteur, Ltd. Main Business Overview
  13.2.5 Sanofi Pasteur, Ltd. Latest Developments
13.3 Merck
  13.3.1 Merck Company Information
  13.3.2 Merck DTaP Vaccine Product Portfolios and Specifications
  13.3.3 Merck DTaP Vaccine Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Merck Main Business Overview
  13.3.5 Merck Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. DTaP Vaccine Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. DTaP Vaccine Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Inactivated Vaccine
Table 4. Major Players of Live Attenuated Vaccine
Table 5. Global DTaP Vaccine Sales by Type (2018-2023) & (K Doses)
Table 6. Global DTaP Vaccine Sales Market Share by Type (2018-2023)
Table 7. Global DTaP Vaccine Revenue by Type (2018-2023) & ($ million)
Table 8. Global DTaP Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global DTaP Vaccine Sale Price by Type (2018-2023) & (US$/Dose)
Table 10. Global DTaP Vaccine Sales by Application (2018-2023) & (K Doses)
Table 11. Global DTaP Vaccine Sales Market Share by Application (2018-2023)
Table 12. Global DTaP Vaccine Revenue by Application (2018-2023)
Table 13. Global DTaP Vaccine Revenue Market Share by Application (2018-2023)
Table 14. Global DTaP Vaccine Sale Price by Application (2018-2023) & (US$/Dose)
Table 15. Global DTaP Vaccine Sales by Company (2018-2023) & (K Doses)
Table 16. Global DTaP Vaccine Sales Market Share by Company (2018-2023)
Table 17. Global DTaP Vaccine Revenue by Company (2018-2023) ($ Millions)
Table 18. Global DTaP Vaccine Revenue Market Share by Company (2018-2023)
Table 19. Global DTaP Vaccine Sale Price by Company (2018-2023) & (US$/Dose)
Table 20. Key Manufacturers DTaP Vaccine Producing Area Distribution and Sales Area
Table 21. Players DTaP Vaccine Products Offered
Table 22. DTaP Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global DTaP Vaccine Sales by Geographic Region (2018-2023) & (K Doses)
Table 26. Global DTaP Vaccine Sales Market Share Geographic Region (2018-2023)
Table 27. Global DTaP Vaccine Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global DTaP Vaccine Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global DTaP Vaccine Sales by Country/Region (2018-2023) & (K Doses)
Table 30. Global DTaP Vaccine Sales Market Share by Country/Region (2018-2023)
Table 31. Global DTaP Vaccine Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global DTaP Vaccine Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas DTaP Vaccine Sales by Country (2018-2023) & (K Doses)
Table 34. Americas DTaP Vaccine Sales Market Share by Country (2018-2023)
Table 35. Americas DTaP Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas DTaP Vaccine Revenue Market Share by Country (2018-2023)
Table 37. Americas DTaP Vaccine Sales by Type (2018-2023) & (K Doses)
Table 38. Americas DTaP Vaccine Sales by Application (2018-2023) & (K Doses)
Table 39. APAC DTaP Vaccine Sales by Region (2018-2023) & (K Doses)
Table 40. APAC DTaP Vaccine Sales Market Share by Region (2018-2023)
Table 41. APAC DTaP Vaccine Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC DTaP Vaccine Revenue Market Share by Region (2018-2023)
Table 43. APAC DTaP Vaccine Sales by Type (2018-2023) & (K Doses)
Table 44. APAC DTaP Vaccine Sales by Application (2018-2023) & (K Doses)
Table 45. Europe DTaP Vaccine Sales by Country (2018-2023) & (K Doses)
Table 46. Europe DTaP Vaccine Sales Market Share by Country (2018-2023)
Table 47. Europe DTaP Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe DTaP Vaccine Revenue Market Share by Country (2018-2023)
Table 49. Europe DTaP Vaccine Sales by Type (2018-2023) & (K Doses)
Table 50. Europe DTaP Vaccine Sales by Application (2018-2023) & (K Doses)
Table 51. Middle East & Africa DTaP Vaccine Sales by Country (2018-2023) & (K Doses)
Table 52. Middle East & Africa DTaP Vaccine Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa DTaP Vaccine Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa DTaP Vaccine Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa DTaP Vaccine Sales by Type (2018-2023) & (K Doses)
Table 56. Middle East & Africa DTaP Vaccine Sales by Application (2018-2023) & (K Doses)
Table 57. Key Market Drivers & Growth Opportunities of DTaP Vaccine
Table 58. Key Market Challenges & Risks of DTaP Vaccine
Table 59. Key Industry Trends of DTaP Vaccine
Table 60. DTaP Vaccine Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. DTaP Vaccine Distributors List
Table 63. DTaP Vaccine Customer List
Table 64. Global DTaP Vaccine Sales Forecast by Region (2024-2029) & (K Doses)
Table 65. Global DTaP Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas DTaP Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 67. Americas DTaP Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC DTaP Vaccine Sales Forecast by Region (2024-2029) & (K Doses)
Table 69. APAC DTaP Vaccine Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe DTaP Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 71. Europe DTaP Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa DTaP Vaccine Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Middle East & Africa DTaP Vaccine Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global DTaP Vaccine Sales Forecast by Type (2024-2029) & (K Doses)
Table 75. Global DTaP Vaccine Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global DTaP Vaccine Sales Forecast by Application (2024-2029) & (K Doses)
Table 77. Global DTaP Vaccine Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. GlaxoSmithKline Basic Information, DTaP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. GlaxoSmithKline DTaP Vaccine Product Portfolios and Specifications
Table 80. GlaxoSmithKline DTaP Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 81. GlaxoSmithKline Main Business
Table 82. GlaxoSmithKline Latest Developments
Table 83. Sanofi Pasteur, Ltd. Basic Information, DTaP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Sanofi Pasteur, Ltd. DTaP Vaccine Product Portfolios and Specifications
Table 85. Sanofi Pasteur, Ltd. DTaP Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 86. Sanofi Pasteur, Ltd. Main Business
Table 87. Sanofi Pasteur, Ltd. Latest Developments
Table 88. Merck Basic Information, DTaP Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. Merck DTaP Vaccine Product Portfolios and Specifications
Table 90. Merck DTaP Vaccine Sales (K Doses), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2018-2023)
Table 91. Merck Main Business
Table 92. Merck Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of DTaP Vaccine
Figure 2. DTaP Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global DTaP Vaccine Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global DTaP Vaccine Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. DTaP Vaccine Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Inactivated Vaccine
Figure 10. Product Picture of Live Attenuated Vaccine
Figure 11. Global DTaP Vaccine Sales Market Share by Type in 2022
Figure 12. Global DTaP Vaccine Revenue Market Share by Type (2018-2023)
Figure 13. DTaP Vaccine Consumed in Government Institution
Figure 14. Global DTaP Vaccine Market: Government Institution (2018-2023) & (K Doses)
Figure 15. DTaP Vaccine Consumed in Private Sector
Figure 16. Global DTaP Vaccine Market: Private Sector (2018-2023) & (K Doses)
Figure 17. DTaP Vaccine Consumed in Other
Figure 18. Global DTaP Vaccine Market: Other (2018-2023) & (K Doses)
Figure 19. Global DTaP Vaccine Sales Market Share by Application (2022)
Figure 20. Global DTaP Vaccine Revenue Market Share by Application in 2022
Figure 21. DTaP Vaccine Sales Market by Company in 2022 (K Doses)
Figure 22. Global DTaP Vaccine Sales Market Share by Company in 2022
Figure 23. DTaP Vaccine Revenue Market by Company in 2022 ($ Million)
Figure 24. Global DTaP Vaccine Revenue Market Share by Company in 2022
Figure 25. Global DTaP Vaccine Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global DTaP Vaccine Revenue Market Share by Geographic Region in 2022
Figure 27. Americas DTaP Vaccine Sales 2018-2023 (K Doses)
Figure 28. Americas DTaP Vaccine Revenue 2018-2023 ($ Millions)
Figure 29. APAC DTaP Vaccine Sales 2018-2023 (K Doses)
Figure 30. APAC DTaP Vaccine Revenue 2018-2023 ($ Millions)
Figure 31. Europe DTaP Vaccine Sales 2018-2023 (K Doses)
Figure 32. Europe DTaP Vaccine Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa DTaP Vaccine Sales 2018-2023 (K Doses)
Figure 34. Middle East & Africa DTaP Vaccine Revenue 2018-2023 ($ Millions)
Figure 35. Americas DTaP Vaccine Sales Market Share by Country in 2022
Figure 36. Americas DTaP Vaccine Revenue Market Share by Country in 2022
Figure 37. Americas DTaP Vaccine Sales Market Share by Type (2018-2023)
Figure 38. Americas DTaP Vaccine Sales Market Share by Application (2018-2023)
Figure 39. United States DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC DTaP Vaccine Sales Market Share by Region in 2022
Figure 44. APAC DTaP Vaccine Revenue Market Share by Regions in 2022
Figure 45. APAC DTaP Vaccine Sales Market Share by Type (2018-2023)
Figure 46. APAC DTaP Vaccine Sales Market Share by Application (2018-2023)
Figure 47. China DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 51. India DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe DTaP Vaccine Sales Market Share by Country in 2022
Figure 55. Europe DTaP Vaccine Revenue Market Share by Country in 2022
Figure 56. Europe DTaP Vaccine Sales Market Share by Type (2018-2023)
Figure 57. Europe DTaP Vaccine Sales Market Share by Application (2018-2023)
Figure 58. Germany DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 59. France DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa DTaP Vaccine Sales Market Share by Country in 2022
Figure 64. Middle East & Africa DTaP Vaccine Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa DTaP Vaccine Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa DTaP Vaccine Sales Market Share by Application (2018-2023)
Figure 67. Egypt DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country DTaP Vaccine Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of DTaP Vaccine in 2022
Figure 73. Manufacturing Process Analysis of DTaP Vaccine
Figure 74. Industry Chain Structure of DTaP Vaccine
Figure 75. Channels of Distribution
Figure 76. Global DTaP Vaccine Sales Market Forecast by Region (2024-2029)
Figure 77. Global DTaP Vaccine Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global DTaP Vaccine Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global DTaP Vaccine Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global DTaP Vaccine Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global DTaP Vaccine Revenue Market Share Forecast by Application (2024-2029)